Sars-cov-2 vaccines
US-2024408193-A1 · Dec 12, 2024 · US
Recombinant baculovirus vector and uses thereof
US9328147B2 · US · B2
| Field | Value |
|---|---|
| Publication number | US-9328147-B2 |
| Application number | US-201414478870-A |
| Country | US |
| Kind code | B2 |
| Filing date | Sep 5, 2014 |
| Priority date | Sep 5, 2014 |
| Publication date | May 3, 2016 |
| Grant date | May 3, 2016 |
How to read this patent
A practical reading order for non-experts. Skip the full description unless you need deep technical detail.
- Title
What the patent document calls the invention.
- Abstract
A short plain-language summary of the technical disclosure.
- Assignees and inventors
Who owns or filed the patent and who is credited as inventor.
- Key dates
Filing, priority, publication, and grant dates set the timeline.
- First independent claim
The legal scope of protection — read this for what is actually claimed.
- CPC / IPC classifications
Technology tags used to group this patent with similar filings.
- Citations and related patents
Prior art links and similar publications in this corpus.
Abstract
Official abstract text for this publication.
Disclosed herein is a recombinant viral construct and its uses thereof. The recombinant viral construct is capable of simultaneously expressing three exogenous proteins, including a classical swine fever virus (CSFV) antigen, a porcine circovirus type 2 (PCV2) antigen, and an immunomodulatory protein. The recombinant viral construct is hence useful as a bio-tool for simultaneously producing multiple antigens of a bi-subunit vaccine.
First claim
Opening claim text (preview).
What is claimed is: 1. A recombinant viral construct for producing a bi-subunit vaccine, comprising, a promoter; a first expression cassette, operably linked to the promoter, wherein the first expression cassette comprises in sequence, a first nucleic acid encoding a classical swine fever virus (CSFV) antigen, a self-cleaving element encoding a self-cleaving peptide, and a second nucleic acid encoding a porcine circovirus type 2 (PCV2) antigen; a second expression cassette,…
Assignees
Inventors
Classifications
- A61K39/12Primary
Human Necessities · mapped topic
Chemistry & Metallurgy · mapped topic
Chemistry & Metallurgy · mapped topic
- C07K14/005Primary
Chemistry & Metallurgy · mapped topic
Human Necessities · mapped topic
Patent family
Related publications grouped by family.
External sources
Next steps
Free tools are coming soon. Tell us what you want to track and we'll notify you.
Frequently asked questions
Answers are generated from the same data shown on this page.
- What does patent US9328147B2 cover?
- Disclosed herein is a recombinant viral construct and its uses thereof. The recombinant viral construct is capable of simultaneously expressing three exogenous proteins, including a classical swine fever virus (CSFV) antigen, a porcine circovirus type 2 (PCV2) antigen, and an immunomodulatory protein. The recombinant viral construct is hence useful as a bio-tool for simultaneously producing m…
- Who is the assignee on this patent?
- Univ Chung Yuan Christian
- What technology area does this patent fall under?
- Primary CPC classification A61K39/12. Mapped technology areas include Human Necessities.
- When was this patent published?
- Publication date Tue May 03 2016 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
- What related patents are in patentsdb?
- We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).